Skip to main content
Log in

Absorbable mesh in a contaminated field: hernia repair outcomes

  • Original Article
  • Published:
Updates in Surgery Aims and scope Submit manuscript

Abstract

Hernia repair mesh aids in the stability of incisional hernia repair and can reduce the need for subsequent operations. There is, however, debate among surgeons over which type of hernia mesh—synthetics, biologics, or biosynthetics—is indicated as best for specific patients. A retrospective case review comparing surgical outcomes based on wound class and mesh materials may provide insights into this question. This study evaluates patient outcomes using biosynthetic mesh based upon CDC wound classification. Following Institutional Review Board approval, the local National Surgery Quality Improvement (NSQIP) databases were queried for open ventral hernia repaired with absorbable mesh implants from January 2013–December 2017. Factors for comparison included patient demographics, operative details, and an analysis of clinical outcomes. Our study identified 112 ventral hernia repair cases with absorbable mesh placement, 32% (n = 36) were wound classes II–IV. Higher wound class correlated statistically with diabetes (33.3%), prior hernia repair (61.1%), and parastomal hernia (44.4%). Higher wound classes were associated with more emergent presentations, involved bowel resection more frequently, required larger mesh implants, increased post-operative surgical site infections, and wound disruption. Increasing wound class was also associated with longer hospital stays and greater need for readmission (38.9% vs. 11.8%). Compared to patients with clean wounds, biosynethic mesh repair patients with contaminated wounds exhibited more emergent presentations, increased incidence of bowel resection, increased mesh size, and more readmissions. Despite these peri-operative outcomes, hernia recurrence rates among biosynethic mesh hernia repair were similar in CDC class II–IV patients as class I.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Dietz UA, Menzel S, Lock J, Wiegering A (2018) The treatment of incisional hernia. Dtsch Arztebl Int 115(3):31–37. https://doi.org/10.3238/arztebl.2018.0031

    Article  PubMed  Google Scholar 

  2. Vauclair E, Bert M, Facy O, Cheynel N, Rat P, Ortega-Deballon P (2021) What results can be expected one year after complex incisional hernia repair with biosynthetic mesh? J Visc Surg 158(2):111–117. https://doi.org/10.1016/j.jviscsurg.2020.07.008

    Article  CAS  PubMed  Google Scholar 

  3. Kao AM, Arnold MR, Augenstein VA, Heniford BT (2018) Prevention and treatment strategies for mesh infection in abdominal wall reconstruction. Plast Reconstr Surg 142(3 Suppl):149S-155S. https://doi.org/10.1097/PRS.0000000000004871

    Article  CAS  PubMed  Google Scholar 

  4. Parker MJ, Kim RC, Barrio M, Socas J, Reed LR, Nakeeb A, House MG, Ceppa EP (2020) A novel biosynthetic scaffold mesh reinforcement affords the lowest hernia recurrence in the highest-risk patients. Surg Endosc 35(9):5173–5178. https://doi.org/10.1007/s00464-020-08009-1

    Article  PubMed  Google Scholar 

  5. Rosen MJ, Bauer JJ, Harmaty M et al (2017) Multicenter, prospective, longitudinal study of the recurrence, surgical site infection, and quality of life after contaminated ventral hernia repair using biosynthetic absorbable mesh: the COBRA study. Ann Surg 265(1):205–211. https://doi.org/10.1097/SLA.0000000000001601

    Article  PubMed  Google Scholar 

  6. Smith A, Slater K (2021) Outcomes of biosynthetic absorbable mesh use in high risk CDC class I ventral hernia repair: a single surgeon series. Hernia 26(1):97–108. https://doi.org/10.1007/s10029-021-02424-6

    Article  PubMed  Google Scholar 

  7. Herman TF, Bordoni B (2022) Wound classification. StatPearls Publishing, Tampa, FL

    Google Scholar 

  8. Raigani S, Criss CN, Petro CC, Prabhu AS, Novitsky YW, Rosen MJ (2014) Single-center experience with parastomal hernia repair using retromuscular mesh placement. J Gastrointest Surg 18(9):1673–1677. https://doi.org/10.1007/s11605-014-2575-4

    Article  PubMed  Google Scholar 

  9. Cross AJ, Buchwald PL, Frizelle FA, Eglinton TW (2017) Meta-analysis of prophylactic mesh to prevent parastomal hernia. Br J Surg 104(3):179–186. https://doi.org/10.1002/bjs.10402

    Article  CAS  PubMed  Google Scholar 

  10. Cornille JB, Pathak S, Daniels IR, Smart NJ (2017) Prophylactic mesh use during primary stoma formation to prevent parastomal hernia. Ann R Coll Surg Engl 99(1):2–11. https://doi.org/10.1308/rcsann.2016.0186

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Shabbir J, Chaudhary BN, Dawson R (2012) A systematic review on the use of prophylactic mesh during primary stoma formation to prevent parastomal hernia formation. Colorectal Dis 14(8):931–936. https://doi.org/10.1111/j.1463-1318.2011.02835.x

    Article  CAS  PubMed  Google Scholar 

  12. Tam KW, Wei PL, Kuo LJ, Wu CH (2010) Systematic review of the use of a mesh to prevent parastomal hernia. World J Surg 34(11):2723–2729. https://doi.org/10.1007/s00268-010-0739-2

    Article  PubMed  Google Scholar 

  13. Wijeyekoon SP, Gurusamy K, El-Gendy K, Chan CL (2010) Prevention of parastomal herniation with biologic/composite prosthetic mesh: a systematic review and meta-analysis of randomized controlled trials. J Am Coll Surg 211(5):637–645. https://doi.org/10.1016/j.jamcollsurg.2010.06.111

    Article  PubMed  Google Scholar 

  14. Sahebally SM, Lim TZ, Azmir AA et al (2021) Prophylactic mesh placement at index permanent end colostomy creation to prevent parastomal hernia-an updated meta-analysis. Int J Colorectal Dis 36(9):2007–2016. https://doi.org/10.1007/s00384-021-03924-8

    Article  PubMed  Google Scholar 

  15. Odensten C, Strigård K, Rutegård J et al (2019) Use of prophylactic mesh when creating a colostomy does not prevent parastomal hernia: a randomized controlled trial-STOMAMESH. Ann Surg 269(3):427–431. https://doi.org/10.1097/SLA.0000000000002542

    Article  PubMed  Google Scholar 

  16. Pizza F, D’Antonio D, Lucido FS, Del Rio P, Dell’Isola C, Brusciano L, Tolone S, Docimo L, Gambardella C (2022) Is absorbable mesh useful in preventing parastomal hernia after emergency surgery? The PARTHENOPE study. Hernia 26(2):507–516. https://doi.org/10.1007/s10029-022-02579-w

    Article  CAS  PubMed  Google Scholar 

  17. Pizza F, D’Antonio D, Ronchi A, Lucido FS, Brusciano L, Marvaso A, Dell’Isola C, Gambardella C (2021) Prophylactic sublay non-absorbable mesh positioning following midline laparotomy in a clean-contaminated field: randomized clinical trial (PROMETHEUS). Br J Surg 108(6):638–643. https://doi.org/10.1093/bjs/znab068

    Article  CAS  PubMed  Google Scholar 

  18. Schneeberger S, Phillips S, Huang LC, Pierce RA, Etemad SA, Poulose BK (2019) Cost-utility analysis of biologic and biosynthetic mesh in ventral hernia repair: when are they worth It? J Am Coll Surg 228(1):66–71. https://doi.org/10.1016/j.jamcollsurg.2018.10.009

    Article  PubMed  Google Scholar 

  19. Totten CF, Davenport DL, Ward ND, Roth JS (2016) Cost of ventral hernia repair using biologic or synthetic mesh. J Surg Res 203(2):459–465. https://doi.org/10.1016/j.jss.2016.02.040

    Article  PubMed  Google Scholar 

  20. Davila DG, Parikh N, Frelich MJ, Goldblatt MI (2016) The increased cost of ventral hernia recurrence: a cost analysis. Hernia 20(6):811–817. https://doi.org/10.1007/s10029-016-1515-5

    Article  CAS  PubMed  Google Scholar 

  21. Plymale MA, Davenport DL, Walsh-Blackmore S, Hess J, Griffiths WS, Plymale MC (2020) Costs and complications associated with infected mesh for ventral hernia repair. Surg Infect (Larchmt) 21(4):344–349. https://doi.org/10.1089/sur.2019.183

    Article  PubMed  Google Scholar 

Download references

Funding

This research received no grant from any funding agency in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Brittany E. Levy.

Ethics declarations

Conflict of interest

The authors declare there are no conflicts of interest associated with the content of this manuscript. Brittany Levy, MD has served as a consultant to Ethicon, Johnson and Johnson. Crystal Totten, MD has served as a consultant to Becton Dickinson John S. Roth, MD has received research grants from Becton Dickinson, Advanced Medical Solutions, and W.L. Gore. He also served as consultant to Becton Dickinson, Medtronic, and Abbvie.

Research involving human participants and/or animals, and Informed consent

This retrospective cohort study was approved under an expedited status with a waiver of informed consent, due to no more than minimal risk to the study participants. 

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wagner, V., Levy, B.E., Castle, J.T. et al. Absorbable mesh in a contaminated field: hernia repair outcomes. Updates Surg 75, 1337–1342 (2023). https://doi.org/10.1007/s13304-022-01433-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13304-022-01433-z

Keywords

Navigation